Cancer BiologybioRxiv
HDAC and MAPK/ERK inhibitors cooperate to reduce viability and stemness phenotype in medulloblastoma
M. d. C. Jaeger, E. C. Ghisleni, P. S. Cardoso…·R. Roesler
This study shows that combining HDAC and MAPK/ERK inhibitors reduces medulloblastoma cell viability and stemness by modulating chromatin state and signaling pathways.
DOI 10.1007/s12031-020-01505-y